FDA Investigator Erin M Mcdowell
Erin M Mcdowell has inspections in 2 countries as of 14 Sep 2023. Erin M Mcdowell has collaborated with a combined 1302 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
7
Last Inspection Date:
14 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Canada
Co-Investigator(s):
Amber G Chung,
Ana P Barido,
Andrew R Wasko,
Arindam Dasgupta, PhD,
Barbar J Breithaupt,
Barbara J Holladay,
Barbara Janine Breithaupt,
Brandon L Mariner,
Carl A Anderson,
Charles A Snipes, PhD,
Charles R Bonapace, PhD,
Christina A Miller,
Christine M Smith,
Connie P Rezendes,
Courtney N Long,
Ct Viswanathan, PhD,
Cynthia A Harris, MD, RN,
Cynthia Jim, CSO,
Da Lin Yao, MD, PhD,
David K Glasgow,
David L Chon,
Debra L Boyd Seale,
Donald B Mckechnie,
Dr. Mark J Seaton, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Dustin P Tran,
Dylan Yao,
Erin Mcdowell,
Gloria A Milster,
Grace P Santos,
Hanna L Potter,
Heika R Bounds,
Heika R Tait,
Hugh M Mcclure, II,
Jacqueline A O'shaughnessy, PhD,
James W Plucinski,
Jane M Kreis,
Jeanne J Thai,
Jennifer C Adams,
Jennifer C Johnson,
John A Kadavil, PhD,
John Dan,
Jonathan R Campos,
Julian C Hanson,
Jyoti B Patel, PhD,
Kathleen S Tormey,
Kathryn A Krentz,
Kujtim Sadiku,
Lakisha M Williams,
Linda S Leja,
Lisa Hayka,
Lori J Silverstein,
Maria Pkelly Doggett, MBA,
Michael F Skelly, PhD,
Nathan R Moon,
Nicole C Victoria, PhD,
Rafael Padilla,
Roberta W Cunningham,
Ronda R Loyd Jones,
Ruth A Williams,
Stacey A Priest,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Sunitha K Rajaram, PhD,
Susan D Yuscius,
Teena H Aiken,
Theressa B Smith,
Tong Zhou,
Young M Yoon
Erin M Mcdowell's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2020 | EIR | Lovelace Biomedical Research Institute - EIR, 2020-01-31 |
January, 2020 | FDA 483 Response | Lovelace Biomedical Research Institute - Form 483R, 2020-02-20 |
November, 2012 | FDA 483 | Victor M. Priego, M.D. - Form 483, 2012-11-02 |
July, 2023 | FDA 483 | Altasciences Preclinical Seattle, LLC - Form 483, 2023-07-14 |
January, 2020 | FDA 483 | Lovelace Biomedical Research Institute - Form 483, 2020-01-31 |
November, 2012 | EIR | Victor M. Priego, M.D. - EIR, 2012-11-02 |
March, 2023 | FDA 483 | Experimur, A Frontage Company - Form 483, 2023-03-10 |
December, 2023 | FDA 483 | IIT Research Institute - Form 483, 2023-12-01 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more